financetom
Business
financetom
/
Business
/
--Ladder Capital Keeps Quarterly Dividend at $0.23/Class A Share, Payable Oct. 15 to Shareholders of Record Sept. 30
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Ladder Capital Keeps Quarterly Dividend at $0.23/Class A Share, Payable Oct. 15 to Shareholders of Record Sept. 30
Sep 13, 2024 12:11 PM

10:17 AM EDT, 09/13/2024 (MT Newswires) --

Price: 12.08, Change: +0.03, Percent Change: +0.27

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eli Lilly Bets Big On Eye Gene Therapy That Could End Repeat Injections
Eli Lilly Bets Big On Eye Gene Therapy That Could End Repeat Injections
Oct 24, 2025
Eli Lilly and Company ( LLY ) and Adverum Biotechnologies, Inc. ( ADVM ) on Friday announced that they have entered into a definitive agreement under which Lilly will acquire Adverum Biotechnologies ( ADVM ), including its lead product, Ixo-vec. Acquisition Terms and Contingent Value Rights (CVR) Under the merger terms, Eli Lilly ( LLY ) will launch a tender...
Intel's Q3 'Significant Upside' is Encouraging, Morgan Stanley Says
Intel's Q3 'Significant Upside' is Encouraging, Morgan Stanley Says
Oct 24, 2025
11:13 AM EDT, 10/24/2025 (MT Newswires) -- Intel's ( INTC ) significant upside in its Q3 results released late Thursday, especially in margins, was encouraging, Morgan Stanley said in a note Friday. The company's Q3 gross margins were notably better, and there are strong conditions evident throughout the businesses, the note said, adding demand for microprocessors is pretty good. The...
Eli Lilly to Acquire Eye Gene Therapy Developer Adverum Biotechnologies
Eli Lilly to Acquire Eye Gene Therapy Developer Adverum Biotechnologies
Oct 24, 2025
11:14 AM EDT, 10/24/2025 (MT Newswires) -- Eli Lilly ( LLY ) has agreed to acquire Adverum Biotechnologies ( ADVM ) , which is developing a therapy to treat vision loss, in a deal worth up to $12.47 per share, the companies said in a joint statement Friday. Adverum's lead product candidate, Ixo-vec, is in a phase 3 trial for...
Ford Motor's 2025 Guidance Drew Investor Focus but Underlying Business is 'Strong', BofA Says
Ford Motor's 2025 Guidance Drew Investor Focus but Underlying Business is 'Strong', BofA Says
Oct 24, 2025
11:13 AM EDT, 10/24/2025 (MT Newswires) -- Ford Motor's ( F ) 2025 adjusted earnings before interest and taxes, or EBIT, guidance drew lots of investor attention, but its underlying business is strong, performing $1 billion ahead of the assumptions provided in Q4, analysts at BofA Securities said in a Friday note. The company projects adjusted EBIT at $6 billion...
Copyright 2023-2026 - www.financetom.com All Rights Reserved